MCC was established in 2019 and has an extensive doctor and patient network that enables eligible patients to access high-quality and affordable medicinal cannabis products.
Since incorporation, MCC has facilitated over 4,000 medical consultations with pre-screened eligible patients and has shown continued month-on-month growth.
The clinic utilises video telemedicine, allowing its doctors to prescribe the range of cannabinoid medications available in Australia.
This transaction provides MGC Pharma with turnkey access to over 600 pharmacy accounts and patients can also leverage on existing seamless delivery infrastructure so medication can be dispensed and delivered straight to the patient’s door, eliminating the need for multiple visits to both doctor and pharmacy.
“Improves distribution network and supply chain capabilities”
MGC Pharma co-founder and managing director Roby Zomer said: “We are very pleased to complete the acquisition of MCC.
“As previously announced, this acquisition significantly improves our distribution network and…